<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, viewport-fit=cover">
    <meta name="description" content="Evidence-based clinical resource for liver transplantation in unresectable colorectal liver metastases. Includes prognostic scoring systems, interactive calculators, survival data, and clinical guidelines.">
    <meta name="keywords" content="liver transplantation, colorectal metastases, CRLM, transplant oncology, Oslo Score, clinical resource, transplant surgery">
    <meta name="author" content="Tor Magnus Smedman, MD PhD">
    <meta name="robots" content="index, follow">
    <meta property="og:title" content="CRLM LT Clinical Resource - Evidence-Based Liver Transplantation Guide">
    <meta property="og:description" content="Comprehensive clinical resource for transplant teams evaluating patients with unresectable colorectal liver metastases for liver transplantation.">
    <meta property="og:type" content="website">
    <meta property="og:url" content="https://Magnustheboss.github.io/LT-for-CRLM/">
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:title" content="CRLM LT Clinical Resource">
    <meta name="twitter:description" content="Evidence-based information for transplant teams on liver transplantation for colorectal metastases.">
    <link rel="canonical" href="https://Magnustheboss.github.io/LT-for-CRLM/">
    <title>CRLM LT Clinical Resource - Liver Transplantation for Colorectal Metastases</title>
    <link rel="stylesheet" href="css/style.css">
</head>
<body>
    <!-- Navigation -->
    <nav class="navbar">
        <div class="container">
            <div class="logo">CRLM LT Resource</div>
            <button class="hamburger" id="hamburger" aria-label="Toggle menu">
                <span></span>
                <span></span>
                <span></span>
            </button>
            <ul class="nav-menu" id="navMenu">
                <li><a href="index.html" class="active">Home</a></li>
                <li><a href="pages/overview.html">Overview</a></li>
                <li><a href="pages/selection-criteria.html">Selection Criteria</a></li>
                <li><a href="pages/outcomes.html">Clinical Outcomes</a></li>
                <li><a href="pages/tools.html">Tools</a></li>
                <li><a href="pages/faq.html">FAQ</a></li>
                <li><a href="pages/glossary.html">Glossary</a></li>
                <li><a href="pages/case-studies.html">Cases</a></li>
                <li><a href="pages/bridging-therapy.html">Bridging Therapy</a></li>
                <li><a href="pages/lt-vs-resection.html">LT vs Resection</a></li>
                <li><a href="pages/resources.html">Resources</a></li>
                <li><a href="pages/about-research-group.html">About Research Group</a></li>
            </ul>
        </div>
    </nav>

    <!-- Hero Section -->
    <section class="hero">
        <div class="container">
            <h1>Liver Transplantation for Colorectal Liver Metastases</h1>
            <p class="subtitle">A Comprehensive Clinical Resource for Transplant Teams</p>
            <p class="description">Evidence-based guidance on patient selection, prognostic factors, and outcomes for LT in unresectable CRLM</p>
            <a href="pages/overview.html" class="cta-button">Start Reading</a>
        </div>
    </section>

    <!-- Key Statistics Section -->
    <section class="statistics">
        <div class="container">
            <h2>Key Evidence at a Glance</h2>
            <div class="stats-grid">
                <div class="stat-card">
                    <div class="stat-number">56.6%</div>
                    <div class="stat-label">5-Year OS with LT + Chemo</div>
                    <div class="stat-source">TransMet Trial</div>
                </div>
                <div class="stat-card">
                    <div class="stat-number">12.6%</div>
                    <div class="stat-label">5-Year OS with Chemo Alone</div>
                    <div class="stat-source">TransMet Trial</div>
                </div>
                <div class="stat-card">
                    <div class="stat-number">83%</div>
                    <div class="stat-label">5-Year OS (SECA-II Selected)</div>
                    <div class="stat-source">Oslo Experience</div>
                </div>
                <div class="stat-card">
                    <div class="stat-number">4.5Ã—</div>
                    <div class="stat-label">Survival Benefit (HR 0.37)</div>
                    <div class="stat-source">TransMet RCT</div>
                </div>
            </div>
        </div>
    </section>

    <!-- Quick Navigation Cards -->
    <section class="quick-nav">
        <div class="container">
            <h2>Quick Navigation</h2>
            <div class="card-grid">
                <a href="pages/overview.html" class="nav-card">
                    <h3>ðŸ“– Overview</h3>
                    <p>Historical context, current evidence, and the re-emergence of LT for CRLM</p>
                </a>
                <a href="pages/selection-criteria.html" class="nav-card">
                    <h3>âœ“ Selection Criteria</h3>
                    <p>Oslo Score, FCRS, PET-MTV, and molecular prognostic factors</p>
                </a>
                <a href="pages/outcomes.html" class="nav-card">
                    <h3>ðŸ“Š Clinical Outcomes</h3>
                    <p>Survival data, recurrence patterns, and comparative analyses</p>
                </a>
                <a href="pages/resources.html" class="nav-card">
                    <h3>ðŸ”— Resources</h3>
                    <p>References, guidelines, and ongoing clinical trials</p>
                </a>
            </div>
        </div>
    </section>

    <!-- Key Takeaways -->
    <section class="takeaways">
        <div class="container">
            <h2>Key Takeaways for Clinical Practice</h2>
            <div class="takeaway-list">
                <div class="takeaway-item">
                    <div class="takeaway-number">1</div>
                    <div class="takeaway-content">
                        <h4>LT is now a validated standard option</h4>
                        <p>The TransMet RCT demonstrates that LT plus chemotherapy significantly improves 5-year OS (56.6% vs. 12.6%) compared to chemotherapy alone in permanently unresectable CRLM.</p>
                    </div>
                </div>
                <div class="takeaway-item">
                    <div class="takeaway-number">2</div>
                    <div class="takeaway-content">
                        <h4>Rigorous patient selection is essential</h4>
                        <p>Use of the Oslo Score, FCRS, PET-MTV, and molecular profiling (especially RAS/TP53 status) ensures selection of patients with favorable tumor biology.</p>
                    </div>
                </div>
                <div class="takeaway-item">
                    <div class="takeaway-number">3</div>
                    <div class="takeaway-content">
                        <h4>Recurrence is common but manageable</h4>
                        <p>While DFS is low, median OS after relapse is 37.1 months, suggesting indolent disease biology in selected patients.</p>
                    </div>
                </div>
                <div class="takeaway-item">
                    <div class="takeaway-number">4</div>
                    <div class="takeaway-content">
                        <h4>LDLT expands access</h4>
                        <p>Living donor LT circumvents deceased donor scarcity and offers comparable or superior outcomes.</p>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer class="footer">
        <div class="container">
            <p>&copy; 2025 CRLM LT Clinical Resource. Evidence-based information for transplant teams.</p>
            <p class="author"><strong>Created by:</strong> Tor Magnus Smedman, MD PhD | Transplant Oncology Research Group, Oslo University Hospital</p>
            <p class="disclaimer">This resource is for educational purposes. Clinical decisions should be made in consultation with a multidisciplinary team.</p>
        </div>
    </footer>

    <script src="js/main.js"></script>
    <script>
        // Hamburger menu toggle
        const hamburger = document.getElementById('hamburger');
        const navMenu = document.getElementById('navMenu');
        
        if (hamburger && navMenu) {
            hamburger.addEventListener('click', function() {
                navMenu.classList.toggle('active');
                hamburger.classList.toggle('active');
            });
            
            // Close menu when a link is clicked
            const navLinks = navMenu.querySelectorAll('a');
            navLinks.forEach(link => {
                link.addEventListener('click', function() {
                    navMenu.classList.remove('active');
                    hamburger.classList.remove('active');
                });
            });
        }
    </script>
</body>
</html>
